Oseltamivir Capsule: Uses, Dosage & Side Effects in Pakistan

Oseltamivir Capsule Uses, Dosage, Side Effects & Price in Pakistan

1. Quick Info (Mukhtasir Maloomat)

2. What is Oseltamivir Capsule? (Oseltamivir Capsule kya hai)

Oseltamivir (Tamiflu) is an antiviral treatment for influenza (flu). It blocks the neuraminidase enzyme — the virus cannot exit infected cells to infect new cells — reducing the duration and severity of flu.

THE 48-HOUR RULE: Tamiflu is only beneficial when taken within 48 hours of flu symptoms starting. After this window, it is generally ineffective in healthy adults. High-risk patients (elderly, pregnant, immunocompromised, CLD, CKD, diabetes, BMI>40) may still benefit after 48 hours.

Pakistan has a genuine H1N1 burden — during flu season, Tamiflu is commonly prescribed for high-risk patients. It cannot replace the flu vaccine.

3. Uses (Fayde / Kis kaam aati hai)

• Treatment of influenza A or B when clinically indicated
• Prevention of influenza after exposure in selected patients

4. Who May Use It (Kis ko leni chahiye)

A healthcare professional should confirm that the indication, age and exact formulation match the patient’s needs. An ingredient match alone does not make another brand or formulation interchangeable.

5. When Not to Use (Kab nahi leni chahiye)

• Start promptly when prescribed. High-risk or hospitalised patients may still need treatment after 48 hours.
• It does not replace influenza vaccination or treat bacterial infection.
• Report confusion, unusual behaviour or serious skin reactions.
• Dose adjustment may be needed in kidney impairment.

6. Dosage (Kitni leni hai)

Adult guidance

For an eligible adult with normal kidney function, a usual treatment course is 75 mg twice daily for 5 days. Prevention uses a different schedule and duration; kidney impairment requires dose adjustment.

Child guidance

As prescribed by paediatrician — weight-based; 30mg and 45mg strengths available for children

Dose limits

Use the limit specified for your exact product and individual prescription. A strength printed on a pack is not automatically a recommended dose.

7. How to Use (Kaise leni hai)

Check the medicine name, strength and instructions before each course. Do not share a prescription or change its dose, duration or formulation without professional advice.

8. Timing (Kab leni chahiye)

Check the local leaflet or ask a pharmacist about food timing for this exact formulation; do not infer it from another medicine.

9. Missed Dose (Dose chhoot jaye)

Follow the exact leaflet or contact a pharmacist for missed-dose instructions. Do not double a dose or change a tapering or monitored treatment plan yourself.

10. Warnings (Ihtiyat)

• Start promptly when prescribed. High-risk or hospitalised patients may still need treatment after 48 hours.
• It does not replace influenza vaccination or treat bacterial infection.
• Report confusion, unusual behaviour or serious skin reactions.
• Dose adjustment may be needed in kidney impairment.

11. Precautions (Ahm ehtiyaat)

Check allergies, pregnancy or breastfeeding, kidney and liver conditions, and all other medicines with the prescriber or pharmacist. Store according to the local pack and keep out of reach of children. Below 25°C, dry place; liquid suspension (when available) refrigerate after reconstitution

12. Side Effects (Nuksanat)

Reported effects

• Nausea
• Vomiting
• Headache
• Abdominal pain

Serious effects and warning symptoms

• Neuropsychiatric events — hallucinations, confusion, self-harm behaviours (especially children/adolescents — FDA warning)
• Hepatitis (rare)
• Stevens-Johnson Syndrome / toxic epidermal necrolysis (very rare — severe rash)

These lists do not establish the frequency of an effect or prove that a new symptom is caused by this medicine. Persistent or worsening symptoms need assessment.

13. Interactions (Dawaon ke sath reaction)

Tell the prescriber about probenecid and the live intranasal influenza vaccine. Timing restrictions differ before and after an antiviral course; confirm with the vaccination service rather than applying a reversed interval.

14. When to Get Help (Kab doctor se milein)

Seek emergency help for difficulty breathing, swelling of the face or throat, collapse, severe bleeding or suspected overdose. For the medicine-specific warning symptoms above, contact a clinician promptly. Bring the pack and a list of medicines.

15. Alternatives (Dusri dawaein)

Ask a pharmacist to compare the exact ingredients, strength, route and release type. A generic name alone does not prove dose equivalence. Do not substitute a combination product for a single-ingredient treatment.

16. Price in Pakistan (Price kitni hai)

A current price matched to the local strength and pack size has not been verified. Confirm the printed price, pack and expiry with a licensed pharmacy.

17. FAQs (Aksar poochay jane walay sawalat)

Q: Oseltamivir Capsule kis kaam aati hai?

A: Oseltamivir Capsule contains Oseltamivir. Treatment of influenza A or B when clinically indicated; Prevention of influenza after exposure in selected patients. The diagnosis and exact product determine suitability.

Q: Dose kaise confirm karein?

A: For an eligible adult with normal kidney function, a usual treatment course is 75 mg twice daily for 5 days. Prevention uses a different schedule and duration; kidney impairment requires dose adjustment.

Q: Bachon ke liye dose kya hai?

A: As prescribed by paediatrician — weight-based; 30mg and 45mg strengths available for children

Q: Pakistan mein price kitni hai?

A: A current price matched to the local strength and pack size has not been verified. Confirm the printed price, pack and expiry with a licensed pharmacy.

Q: Nuksanat hon to kya karein?

A: Reported effects include Nausea; Vomiting; Headache. Seek medical help for Neuropsychiatric events — hallucinations, confusion, self-harm behaviours (especially children/adolescents — FDA warning); Hepatitis (rare). A symptom list does not predict how often an effect occurs.

18. Editorial Information (Medical jaiza)

Compiled by the PakVita Editorial Team · AI-assisted drafting with editorial review · Sourced from DRAP, WHO, BNF · Last updated: 2026-10-15

This correction adds ingredient-specific sources and separates verified facts from unverified local pack details. The recorded medical-review date is unchanged; this editorial correction is not a new clinician review. Foreign labels inform ingredient safety and do not establish Pakistani registration or every local pack’s instructions.

19. Disclaimer (Zaroori tanbeeh)

Educational information only. Confirm the diagnosis, local leaflet and individual prescription with a qualified clinician or pharmacist before starting, stopping or changing treatment.